Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Phorbiplatin, a Highly Potent Pt(IV) Antitumor Prodrug That Can Be Controllably Activated by Red Light
Zhigang Wang, Na Wang, Shun‐Cheung Cheng, et al.
Chem (2019) Vol. 5, Iss. 12, pp. 3151-3165
Open Access | Times Cited: 139

Showing 1-25 of 139 citing articles:

Enhancing the therapeutic efficacy of nanoparticles for cancer treatment using versatile targeted strategies
Hailong Tian, Tingting Zhang, Siyuan Qin, et al.
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 239
The design of small-molecule prodrugs and activatable phototherapeutics for cancer therapy
Hai‐Hao Han, Han-Min Wang, Paramesh Jangili, et al.
Chemical Society Reviews (2023) Vol. 52, Iss. 3, pp. 879-920
Open Access | Times Cited: 156
Metallodrugs in cancer nanomedicine
Quim Peña, Alec Wang, Orysia Zaremba, et al.
Chemical Society Reviews (2022) Vol. 51, Iss. 7, pp. 2544-2582
Closed Access | Times Cited: 144
Photo‐Reduction with NIR Light of Nucleus‐Targeting PtIVNanoparticles for Combined Tumor‐Targeted Chemotherapy and Photodynamic Immunotherapy
Dengshuai Wei, Yun Huang, Bin Wang, et al.
Angewandte Chemie International Edition (2022) Vol. 61, Iss. 20
Closed Access | Times Cited: 143
Targeting drug delivery with light: A highly focused approach
Teresa L. Rapp, Cole A. DeForest
Advanced Drug Delivery Reviews (2021) Vol. 171, pp. 94-107
Open Access | Times Cited: 128
Recent advances of redox-responsive nanoplatforms for tumor theranostics
Miaomiao Chen, Dapeng Liu, Fusheng Liu, et al.
Journal of Controlled Release (2021) Vol. 332, pp. 269-284
Closed Access | Times Cited: 126
Recent advances in the synthesis, stability, and activation of platinum(IV) anticancer prodrugs
Zoufeng Xu, Zhigang Wang, Zhiqin Deng, et al.
Coordination Chemistry Reviews (2021) Vol. 442, pp. 213991-213991
Closed Access | Times Cited: 120
What blocks more anticancer platinum complexes from experiment to clinic: Major problems and potential strategies from drug design perspectives
Kun Peng, Bing‐Bing Liang, Wenting Liu, et al.
Coordination Chemistry Reviews (2021) Vol. 449, pp. 214210-214210
Closed Access | Times Cited: 119
Emerging Strategies in Stimuli-Responsive Prodrug Nanosystems for Cancer Therapy
Chendi Ding, Chunbo Chen, Xiaowei Zeng, et al.
ACS Nano (2022) Vol. 16, Iss. 9, pp. 13513-13553
Open Access | Times Cited: 98
Near-infrared-activated anticancer platinum(IV) complexes directly photooxidize biomolecules in an oxygen-independent manner
Zhiqin Deng, Huangcan Li, Shu Chen, et al.
Nature Chemistry (2023) Vol. 15, Iss. 7, pp. 930-939
Closed Access | Times Cited: 86
Simultaneous Photoactivation of cGAS‐STING Pathway and Pyroptosis by Platinum(II) Triphenylamine Complexes for Cancer Immunotherapy
Yu‐Yi Ling, Xiaoyu Xia, Hao Liang, et al.
Angewandte Chemie International Edition (2022) Vol. 61, Iss. 43
Closed Access | Times Cited: 80
NIR‐II Light Accelerated Prodrug Reduction of Pt(IV)‐Incorporating Pseudo Semiconducting Polymers for Robust Degradation and Maximized Photothermal/Chemo‐Immunotherapy
Dongsheng Tang, Huiling Zhou, Minhui Cui, et al.
Advanced Materials (2023) Vol. 35, Iss. 28
Open Access | Times Cited: 49
Reduction of Platinum(IV) Prodrug Hemoglobin Nanoparticles with Deeply Penetrating Ultrasound Radiation for Tumor‐Targeted Therapeutically Enhanced Anticancer Therapy
Ganghao Liang, Tumpa Sadhukhan, Samya Banerjee, et al.
Angewandte Chemie International Edition (2023) Vol. 62, Iss. 22
Open Access | Times Cited: 48
Bioorthogonal chemistry for prodrug activation in vivo
Qunfeng Fu, Siyong Shen, Pengwei Sun, et al.
Chemical Society Reviews (2023) Vol. 52, Iss. 22, pp. 7737-7772
Closed Access | Times Cited: 46
Recent Advances of Platinum‐Based Anticancer Complexes in Combinational Multimodal Therapy
Tianyuan Zhong, Jie Yu, Yong Pan, et al.
Advanced Healthcare Materials (2023) Vol. 12, Iss. 22
Open Access | Times Cited: 43
An ultrasound-activatable platinum prodrug for sono-sensitized chemotherapy
Gongyuan Liu, Yachao Zhang, Houzong Yao, et al.
Science Advances (2023) Vol. 9, Iss. 25
Open Access | Times Cited: 42
Activatable Mitochondria‐Targeting Organoarsenic Prodrugs for Bioenergetic Cancer Therapy
Xiangjie Luo, Xuanqing Gong, Liyun Su, et al.
Angewandte Chemie International Edition (2020) Vol. 60, Iss. 3, pp. 1403-1410
Closed Access | Times Cited: 101
Platinum(IV) antitumor complexes and their nano-drug delivery
Chunyan Jia, Glen B. Deacon, Yingjie Zhang, et al.
Coordination Chemistry Reviews (2020) Vol. 429, pp. 213640-213640
Closed Access | Times Cited: 87
Precise Subcellular Organelle Targeting for Boosting Endogenous‐Stimuli‐Mediated Tumor Therapy
Wenyao Zhen, Shangjie An, Shuqi Wang, et al.
Advanced Materials (2021) Vol. 33, Iss. 51
Closed Access | Times Cited: 87
Photocatalytic Pt(IV)‐Coordinated Carbon Dots for Precision Tumor Therapy
Dongbo Guo, Josh Haipeng Lei, Dade Rong, et al.
Advanced Science (2022) Vol. 9, Iss. 36
Open Access | Times Cited: 50
Metal complexes for catalytic and photocatalytic reactions in living cells and organisms
Hugo Madec, Francisca Figueiredo, Kevin Cariou, et al.
Chemical Science (2022) Vol. 14, Iss. 3, pp. 409-442
Open Access | Times Cited: 48
The role of Platinum(IV)-based antitumor drugs and the anticancer immune response in medicinal inorganic chemistry. A systematic review from 2017 to 2022
Shihao Su, Yutong Chen, Pengfei Zhang, et al.
European Journal of Medicinal Chemistry (2022) Vol. 243, pp. 114680-114680
Closed Access | Times Cited: 42
A near-infrared light-activatable Ru(ii)-coumarin photosensitizer active under hypoxic conditions
Enrique Ortega, Anna Rovira, Marta López‐Corrales, et al.
Chemical Science (2023) Vol. 14, Iss. 26, pp. 7170-7184
Open Access | Times Cited: 35
Oxaliplatin and its derivatives – An overview
Paul O'Dowd, Darragh F. Sutcliffe, Darren M. Griffith
Coordination Chemistry Reviews (2023) Vol. 497, pp. 215439-215439
Open Access | Times Cited: 33
Beyond mere DNA damage: Recent progress in platinum(IV) anticancer complexes containing multi-functional axial ligands
Zhiqin Deng, Guangyu Zhu
Current Opinion in Chemical Biology (2023) Vol. 74, pp. 102303-102303
Closed Access | Times Cited: 31
Page 1 - Next Page

Scroll to top